Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PET Evidence of the Effect of Donepezil on Cognitive Performance in an Animal Model of Chemobrain
Ilhan Lim, Hye-Young Joung, Abigail Yu, et al.
BioMed Research International (2016) Vol. 2016, pp. 1-7
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors
Marie Lange, Florence Joly, Janette Vardy, et al.
Annals of Oncology (2019) Vol. 30, Iss. 12, pp. 1925-1940
Open Access | Times Cited: 484
Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases
Lien D. Nguyen, Barbara E. Ehrlich
EMBO Molecular Medicine (2020) Vol. 12, Iss. 6
Open Access | Times Cited: 125
Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions
Benjamin Ongnok, Nipon Chattipakorn, Siriporn C. Chattipakorn
Experimental Neurology (2019) Vol. 324, pp. 113118-113118
Closed Access | Times Cited: 102
Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain
Sara Emad El-Agamy, Amal Kamal Abdel‐Aziz, Ahmed Esmat, et al.
Cancer Chemotherapy and Pharmacology (2019) Vol. 84, Iss. 1, pp. 1-14
Closed Access | Times Cited: 77
Doxorubicin-Induced Cognitive Impairment: The Mechanistic Insights
Jiajia Du, Aoxue Zhang, Jing Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 76
Donepezil Protects Against Doxorubicin-Induced Chemobrain in Rats via Attenuation of Inflammation and Oxidative Stress Without Interfering With Doxorubicin Efficacy
Benjamin Ongnok, Thawatchai Khuanjing, Titikorn Chunchai, et al.
Neurotherapeutics (2021) Vol. 18, Iss. 3, pp. 2107-2125
Open Access | Times Cited: 56
A Review on the Neurotoxic Effects of Doxorubicin
Katarzyna Kamińska, Agnieszka Cudnoch‐Jędrzejewska
Neurotoxicity Research (2023) Vol. 41, Iss. 5, pp. 383-397
Open Access | Times Cited: 26
Cancer related cognitive impairment: a downside of cancer treatment
Kimberly Demos-Davies, Jessica Lawrence, Davis Seelig
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 10
Chemobrain: A review on mechanistic insight, targets and treatments
Vanishree Rao, Rashmi Bhushan, Priyanka Kumari, et al.
Advances in cancer research (2022), pp. 29-76
Closed Access | Times Cited: 30
Chemotherapy-induced cognitive impairments: A systematic review of the animal literature
A. Matsos, Ian N. Johnston
Neuroscience & Biobehavioral Reviews (2019) Vol. 102, pp. 382-399
Closed Access | Times Cited: 53
The microbiota-gut-brain axis: An emerging therapeutic target in chemotherapy-induced cognitive impairment
Courtney B. Subramaniam, Joanne M. Bowen, Marc A. Gladman, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 116, pp. 470-479
Open Access | Times Cited: 40
A narrative review of risk factors and interventions for cancer- related cognitive impairment
Lu Bai, Enyan Yu
Annals of Translational Medicine (2021) Vol. 9, Iss. 1, pp. 72-72
Open Access | Times Cited: 36
Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions
Giovana R. Onzi, Nathalia D’Agustini, Solange Cristina García, et al.
Drug Safety (2022) Vol. 45, Iss. 6, pp. 601-621
Closed Access | Times Cited: 23
The Relationship between Cancer and Dementia: An Updated Review
Yung‐Shuo Kao, Cheng-Chang Yeh, Yifang Chen
Cancers (2023) Vol. 15, Iss. 3, pp. 640-640
Open Access | Times Cited: 13
Advances of neuroimaging in chemotherapy related cognitive impairment (CRCI) of patients with breast cancer
Senbang Yao, Qianqian Zhang, Xinxin Yao, et al.
Breast Cancer Research and Treatment (2023) Vol. 201, Iss. 1, pp. 15-26
Closed Access | Times Cited: 13
Wnt3a/GSK3β/β-catenin Signalling Modulates Doxorubicin-associated Memory Deficits in Breast Cancer
Wen Li, Gan Chen, Sheng Yu, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 8, pp. 5441-5458
Closed Access | Times Cited: 5
Drug-induced dementia: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database
Lisi Xu, Ruonan Zhang, Xiaolin Zhang, et al.
Therapeutic Advances in Neurological Disorders (2025) Vol. 18
Open Access
Peroxisomes contribute to oxidative stress in neurons during doxorubicin-based chemotherapy
Jose F. Moruno-Manchon, Ndidi-Ese Uzor, Shelli R. Kesler, et al.
Molecular and Cellular Neuroscience (2017) Vol. 86, pp. 65-71
Open Access | Times Cited: 47
Advances in Therapeutic Research on Chemotherapy-Related Cognitive Impairment
立石 刘
World Journal of Cancer Research (2025) Vol. 15, Iss. 01, pp. 9-15
Closed Access
Chemobrain as a Product of Growing Success in Chemotherapy - Focus On Glia As Both A Victim And A Cure
Piotr Walczak, Mirosław Janowski
Neuropsychiatry (2019) Vol. 09, Iss. 01
Open Access | Times Cited: 30
Effects of Endocrine Therapy on Cognitive Function in Patients with Breast Cancer: A Comprehensive Review
Lucy Haggstrom, Janette Vardy, Emma‐Kate Carson, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 920-920
Open Access | Times Cited: 18
Modulation of mitochondrial dynamics rescues cognitive function in rats with ‘doxorubicin‐induced chemobrain’ via mitigation of mitochondrial dysfunction and neuroinflammation
Benjamin Ongnok, Chayodom Maneechote, Titikorn Chunchai, et al.
FEBS Journal (2022) Vol. 289, Iss. 20, pp. 6435-6455
Closed Access | Times Cited: 18
Diosgenin normalization of disrupted behavioral and central neurochemical activity after single prolonged stress
Hurmat Malik, Muhammad Usman, Mehreen Arif, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
Modeling neurotoxin-induced neuroinflammation with chemotherapy
Mai F. Tolba, Nada K. Sedky, Marwa A. Ali, et al.
Elsevier eBooks (2022), pp. 403-417
Closed Access | Times Cited: 14
Evaluation of the Adverse Effects of Chronic Exposure to Donepezil (An Acetylcholinesterase Inhibitor) in Adult Zebrafish by Behavioral and Biochemical Assessments
Gilbert Audira, Nguyễn Thị Ngọc Ánh, Bui Thi Ngoc Hieu, et al.
Biomolecules (2020) Vol. 10, Iss. 9, pp. 1340-1340
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top